We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Madrigal Pharmaceuticals, Inc.
Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.
Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...
The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...
Theratechnologies Inc.’s THTX share price has surged by 20.78%, which has investors questioning if this is right time to sell ...
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
Learn how the Mediterranean diet can help manage and even reverse MASH by supporting liver health, reducing inflammation, and ...
For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...
AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
Galmed (GLMD) announced the grant of a new patent related to its lead compound, Aramchol. The patent covers the use of a combination therapy of ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results